{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:26:48Z","timestamp":1778300808084,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104886","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:01:59Z","timestamp":1596308519000},"page":"104886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses"],"prefix":"10.1016","volume":"182","author":[{"given":"Dagmara","family":"Bialy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104886_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/344237","article-title":"Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene","volume":"186","author":"Abed","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds","volume":"11","author":"Abed","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104886_bib3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/AAC.02126-12","article-title":"Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks","volume":"57","author":"Achenbach","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104886_bib4","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - geneva, November 2011 and June 2012","volume":"87","author":"Anonymous","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2020.104886_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7060156","article-title":"The emergence and decennary distribution of clade 2.3.4.4 HPAI H5Nx","volume":"7","author":"Antigua","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2020.104886_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors","volume":"89","author":"Baek","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/viro.1998.9194","article-title":"The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en","volume":"246","author":"Blick","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104886_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/vir.0.017459-0","article-title":"Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic","volume":"91","author":"Boltz","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01580-17","article-title":"Screening for neuraminidase inhibitor resistance markers among avian influenza viruses of the N4, N5, N6, and N8 neuraminidase subtypes","volume":"92","author":"Choi","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/4351009a","article-title":"China's chicken farmers under fire for antiviral abuse","volume":"435","author":"Cyranoski","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104886_bib11","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/ncomms6029","article-title":"Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses","volume":"5","author":"Duan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104886_bib12","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104886_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cmi.2016.07.007","article-title":"Functional balance between neuraminidase and haemagglutinin in influenza viruses","volume":"22","author":"Gaymard","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2020.104886_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1289\/ehp.0900930","article-title":"Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan","volume":"118","author":"Ghosh","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.antiviral.2020.104886_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071230","article-title":"Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir","volume":"8","author":"Gillman","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104886_bib16","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AEM.04034-14","article-title":"Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards","volume":"81","author":"Gillman","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104886_bib17","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/AAC.00886-15","article-title":"Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water","volume":"59","author":"Gillman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2020.104886_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/irv.12044","article-title":"Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses","volume":"7","author":"Govorkova","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104886_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.antiviral.2013.02.013","article-title":"Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring","volume":"98","author":"Govorkova","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104886_bib20","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/jvi.70.3.1818-1827.1996","article-title":"Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en","volume":"70","author":"Gubareva","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318537","article-title":"Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir","volume":"183","author":"Gubareva","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.17.5.865","article-title":"Plaque inhibition assay for drug susceptibility testing of influenza viruses","volume":"17","author":"Hayden","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104886_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","article-title":"Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802","volume":"37","author":"He","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2020.104886_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-2438-7_6","article-title":"The preparation of chicken kidney cell cultures for virus propagation","volume":"1282","author":"Hennion","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104886_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1178258","article-title":"Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift","volume":"326","author":"Hensley","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104886_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.75.1.49","article-title":"The quantitative determination of influenza virus and antibodies by means of red cell agglutination","volume":"75","author":"Hirst","year":"1942","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2020.104886_bib27","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104886_bib28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2006.10.004","article-title":"Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes","volume":"73","author":"Hurt","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104886_bib30","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00334-09","article-title":"In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses","volume":"53","author":"Hurt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104886_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-019-1258-x","article-title":"Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies","volume":"16","author":"Ilyushina","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2020.104886_bib32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1099\/jgv.0.000584","article-title":"Influenza A virus PB1-F2 protein prolongs viral shedding in chickens lengthening the transmission window","volume":"97","author":"James","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/cix334","article-title":"Preliminary epidemiologic assessment of human infections with highly pathogenic avian influenza A(H5N6) virus, China","volume":"65","author":"Jiang","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2009.07.002","article-title":"Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation","volume":"59","author":"Kawai","year":"2009","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2020.104886_bib35","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/jvi.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104886_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104886_bib38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104886_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/0929867003374886","article-title":"Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor","volume":"7","author":"Lew","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104886_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(16)30268-5","article-title":"FDA approves first generic version of Tamiflu","volume":"4","author":"Lobo","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.antiviral.2020.104886_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/jiu447","article-title":"Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan","volume":"211","author":"Marjuki","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/viro.1997.8958","article-title":"Studies of the binding properties of influenza hemagglutinin receptor-site mutants","volume":"241","author":"Martin","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104886_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"McAuley","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104886_bib44","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","article-title":"Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors","volume":"72","author":"McKimm-Breschkin","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib45","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/651605","article-title":"Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts","volume":"50","author":"Memoli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028178","article-title":"Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses","volume":"6","author":"Mori","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104886_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2019.01.006","article-title":"Baloxavir marboxil: the new influenza drug on the market","volume":"35","author":"O'Hanlon","year":"2019","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2020.104886_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016028","article-title":"Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds","volume":"6","author":"Orozovic","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104886_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib50","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/JVI.03306-14","article-title":"Influenza A virus uses intercellular connections to spread to neighboring cells","volume":"89","author":"Roberts","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2020.104886_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s13238-013-3083-0","article-title":"Origin and molecular characterization of the human-infecting H6N1 influenza virus in Taiwan","volume":"4","author":"Shi","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2020.104886_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-019-0567-0","article-title":"Development of effective anti-influenza drugs: congeners and conjugates - a review","volume":"26","author":"Shie","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2020.104886_bib54","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3201\/eid1909.130724","article-title":"R292K substitution and drug susceptibility of influenza A(H7N9) viruses","volume":"19","author":"Sleeman","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib55","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1128\/JVI.01514-15","article-title":"Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses","volume":"89","author":"Song","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","article-title":"Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China","volume":"25","author":"Su","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2020.104886_bib57","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/AAC.42.12.3234","article-title":"Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071","volume":"42","author":"Tai","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104886_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jviromet.2015.08.009","article-title":"Use of embryonated chicken egg as a model to study the susceptibility of avian influenza H9N2 viruses to oseltamivir carboxylate","volume":"224","author":"Tare","year":"2015","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.antiviral.2020.104886_bib59","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104886_bib60","first-page":"449","article-title":"The origin of pandemic influenza","volume":"47","author":"Webster","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2020.104886_bib62","author":"WHO"},{"key":"10.1016\/j.antiviral.2020.104886_bib63","author":"WHO"},{"key":"10.1016\/j.antiviral.2020.104886_bib61","article-title":"Influenza at the human-animal interface","author":"WHO","year":"2018","journal-title":"Summary and Assessment"},{"key":"10.1016\/j.antiviral.2020.104886_bib64","article-title":"Influenza at the human-animal interface","volume":"13","author":"WHO","year":"2019","journal-title":"Summary and Assessment"},{"key":"10.1016\/j.antiviral.2020.104886_bib65","series-title":"Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.antiviral.2020.104886_bib66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.antiviral.2011.11.006","article-title":"The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: implications for the prevalence of oseltamivir resistant variant viruses","volume":"93","author":"Wu","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104886_bib67","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1128\/JVI.01067-07","article-title":"Neuraminidase inhibitor-resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104886_bib68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40506-016-0085-5","article-title":"Japanese surveillance systems and treatment for influenza","volume":"8","author":"Zaraket","year":"2016","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104886_bib69","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1038\/emi.2014.80","article-title":"Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microb. Infect."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:58Z","timestamp":1759062718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":69,"alternative-id":["S0166354220303004"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104886","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/663872","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104886"}}